Health Catalyst Sees FY2026 Sales $246.000M-$249.000M vs $260.780M Est
Benzinga Newsdesk 2 months ago
NewsGuidance
Health Catalyst (NASDAQ:HCAT) sees FY2026 sales of $246.000 million-$249.000 million vs $260.780 million analyst estimate.
Health Catalyst (NASDAQ:HCAT) sees FY2026 sales of $246.000 million-$249.000 million vs $260.780 million analyst estimate.